Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 234 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2019-06-05 | 2019-11-11 | 85607 |
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2019-06-19 | 2019-11-11 | 87060 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-07-12 | 2019-11-25 | 89167 |
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Resolved | 2019-08-07 | 2019-09-23 | 91103 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-08-21 | 2019-09-16 | 92032 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2020-03-27 | 2020-09-09 | 109686 |
| APO-QUINAPRIL/HCTZ | 20MG 25MG | TABLET | Resolved | 2020-04-13 | 2020-09-01 | 111954 |
| APO-QUINAPRIL/HCTZ | 20MG 12.5MG | TABLET | Resolved | 2020-06-04 | 2020-09-14 | 116564 |
| APO-QUINAPRIL/HCTZ | 20MG 12.5MG | TABLET | Resolved | 2020-10-21 | 2020-11-23 | 126774 |
| APO-QUINAPRIL/HCTZ | 10MG 12.5MG | TABLET | Resolved | 2021-02-12 | 2021-05-10 | 133994 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Actual shortage | 2021-11-05 | 2022-05-09 | 148876 |
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2021-11-05 | 2022-05-09 | 148880 |
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Actual shortage | 2021-11-05 | 2022-05-09 | 148883 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Actual shortage | 2022-01-07 | 2022-05-06 | 152332 |
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2022-03-04 | 2022-05-09 | 156039 |
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Actual shortage | 2022-03-25 | 2022-05-09 | 157326 |
| APO-QUININE | 300MG | CAPSULE | Resolved | 2017-09-04 | 2018-04-17 | 20894 |
| APO-QUININE | 200MG | CAPSULE | Resolved | 2017-12-14 | 2018-04-17 | 32809 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2017-03-11 | 2017-05-23 | 466 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-11 | 2017-05-25 | 6516 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
| APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-09-08 | 2018-09-15 | 60867 |
| BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
| COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
| IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
| IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
| IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-07-12 | 2019-07-13 | 89135 |
| IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |